Pharmafile Logo

BIO

- PMLiVE

New dosing option for AZ’s Imfinzi approved in the EU and UK

Additional option extends dosing from two weeks to four weeks

- PMLiVE

Pfizer, Sanofi and others set to increase US drug prices in 2021

Pressure from COVID-19 restrictions leads to drug price increases

- PMLiVE

The Brexit clock is counting down and time is running out

What businesses need to know about post-Brexit immigration

Lifesaving QR Code Wearable Launched to Help Emergency Services

MedTech company Mavin Informatics have just launched mi-SOS, a lifesaving QR code-based medical identity wearable across the UK

Onyx Health

University spin-out fund makes half a million pound first investments

University partnership Northern Accelerator has made over £500,000 worth of investments into two innovative university spin-out businesses in the health and biotech sectors from its £1.7M Seed Investment Fund

Onyx Health

Harnessing Technology to Improve Health and Healthcare

Steven Collens, Chief Executive Officer at MATTER, discusses his professional journey, his work to empower digital health technology startups, and how MATTER is helping businesses define their challenges, identify solutions, and innovate...

Impetus Digital

Innovative Medical Solutions for Postponing and Undoing Age-related Disease

Aubrey de Grey, Chief Science Officer at SENS Research Foundation, explores the concept of using biomedical technology and regenerative medicine to postpone aging-derived debilitation and death. We dive into many questions surrounding...

Impetus Digital

OLED Medical Technology Saving Patient’s Sight During COVID-19 Pandemic

North East MedTech company secures investment agreement with Japanese tech giant

Onyx Health

Accelerating Digital Health Innovation Success

Fard Johnmar, Founder of Enspektos, and Denise Pines, President of the Medical Board of California, discuss the concepts of “FemAging” and “ePatients”, and how COVID-19 has affected both of these. We explore an...

Impetus Digital

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Research Partnership

AstraZeneca AZ

EU will shoulder certain liability costs in AZ COVID-19 vaccine deal

Low-cost deal will see the EU assume responsibility for side-effect claims

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links